Coriell Institute for Medical Research: Single Audit Reports and Findings

Coriell Institute for Medical Research's most recent single audit in the Federal Audit Clearinghouse covers fiscal year 2025, accepted March 31, 2026; the auditor observed on that filing is Baker Tilly US, LLP. It reported no findings. 10 filings from 2016 to 2025 are on record. Data as of 2026-11-06.

Data as of Nov 6, 2026 · Source: Federal Audit Clearinghouse (public data)

Single audits by year

One row per audit year as the Federal Audit Clearinghouse accepted it. The auditor named is the one observed on that filing; Coriell Institute for Medical Research is recorded in CAMDEN, New Jersey under EIN 210672684, and the Clearinghouse records it as a nonprofit. Each report opens on the Clearinghouse itself; how to search the Federal Audit Clearinghouse explains the rest of the reporting package.

Single audits filed by Coriell Institute for Medical Research
Audit yearFiscal year endFederal expendedThreshold appliedAuditor observedOpinionFindingsMW / SDFAC report
20252025-06-30$9,743,893$750,000Baker Tilly US, LLPUnmodified0—2025-06-GSAFAC-0000408536
20242024-06-30$13,839,625$750,000Baker Tilly US, LLPUnmodified0SD2024-06-GSAFAC-0000357722
20232023-06-30$8,739,834$750,000Baker Tilly US, LLPUnmodified0—2023-06-GSAFAC-0000035272
20222022-06-30$7,760,767$750,000Baker Tilly US, LLPUnmodified0—2022-06-CENSUS-0000208143
20212021-06-30$5,021,838$750,000Baker Tilly US, LLPUnmodified0—2021-06-CENSUS-0000208143
20202020-06-30$5,084,478$750,000Baker Tilly US, LLPUnmodified0—2020-06-CENSUS-0000208143
20192019-06-30$4,832,588$750,000Baker Tilly US, LLPUnmodified0—2019-06-CENSUS-0000208143
20182018-06-30$6,891,108$750,000Baker Tilly US, LLPUnmodified0—2018-06-CENSUS-0000208143
20172017-06-30$7,276,034$750,000Baker Tilly US, LLPUnmodified0—2017-06-CENSUS-0000208143
20162016-06-30$6,093,310$750,000Baker Tilly US, LLPUnmodified0—2016-06-CENSUS-0000208143

When is the next single audit due?

If Coriell Institute for Medical Research is again required to have a single audit for the fiscal year ending Jun 30, 2026, the reporting package is due to the Federal Audit Clearinghouse by Mar 30, 2027 at the latest.

Whether an audit is required depends on federal awards expended in that year (the single audit threshold). The rule, 2 CFR 200.512(a): the reporting package is due within 30 calendar days after the auditee receives the auditor's report or nine months after the end of the audit period, whichever is earlier; the date above is the nine-month date, moved to Monday when it falls on a weekend. Last verified: 2026-11-15.

Which federal programs did this organization report?

From the most recent accepted report, as listed on its schedule of expenditures of federal awards (SEFA). "Major" is the designation the auditor made under 2 CFR 200.518, not ours.

Federal programs on the most recent report
ALNProgramExpendedMajor
93.859BIOMEDICAL RESEARCH AND RESEARCH TRAINING$4,077,764Yes
93.397CANCER CENTERS SUPPORT GRANTS$1,822,017Yes
93.172HUMAN GENOME RESEARCH$1,424,474Yes
93.273ALCOHOL RESEARCH PROGRAMS$438,984Yes
93.396CANCER BIOLOGY RESEARCH$300,977Yes
93.839BLOOD DISEASES AND RESOURCES RESEARCH$290,368Yes
93.396CANCER BIOLOGY RESEARCH$224,283Yes
93.395CANCER TREATMENT RESEARCH$190,365Yes
21.027CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS$161,861No
93.172HUMAN GENOME RESEARCH$145,681Yes
12.420MILITARY MEDICAL RESEARCH AND DEVELOPMENT$124,102Yes
47.074BIOLOGICAL SCIENCES$117,091Yes
12.420MILITARY MEDICAL RESEARCH AND DEVELOPMENT$109,884Yes
12.420MILITARY MEDICAL RESEARCH AND DEVELOPMENT$103,483Yes
93.839BLOOD DISEASES AND RESOURCES RESEARCH$85,323Yes
93.172HUMAN GENOME RESEARCH$53,305Yes
93.350NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES$36,216Yes
93.397CANCER CENTERS SUPPORT GRANTS$18,059Yes
93.396CANCER BIOLOGY RESEARCH$17,624Yes
93.839BLOOD DISEASES AND RESOURCES RESEARCH$2,032Yes

What findings did the auditor report?

The reference is the auditor’s; the requirement is the Compliance Supplement category the auditor selected. The finding text itself is not reproduced here; the FAC report linked above carries it in full. What the two severity levels mean: material weakness vs significant deficiency.

The most recent report lists no finding.

Form 990 and IRS registration

Form 990 "accounting fees" (Part IX line 11c) cover all accounting services reported by the organization and are not the price of an audit engagement.

Where to find the return itself, and what our Form 990 data covers: Form 990 lookup.

Most recent return
990 for 2025-06
Total revenue
$25,210,396
Total assets
$37,747,677
Accounting fees (Part IX line 11c)
$150,921
Paid preparer
BAKER TILLY ADVISORY GROUP LP
IRS object id
202611339349306436
NTEE code
U500
Exempt under
501(c)(3)
Ruling year
1954
BMF release
2026-10-20

Read next

How we computed this

Every row comes from the Federal Audit Clearinghouse record named beside it, one report per audit year, with a resubmission superseding the filing it replaces. The auditor is the one named on that filing — it is not a statement about who audits Coriell Institute for Medical Research now. Form 990 figures come from the IRS e-filed return named by its object id. This page exists because the organization filed at least two single audits, or one with a finding.

Cite this page

AuditRadar. “Coriell Institute for Medical Research Single Audit FY2025 (NJ).” https://getauditradar.com/single-audits/nj/coriell-institute-for-medical-research-210672684/. Data as of 2026-11-06.